Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2012

Open Access 01-12-2012 | Oral presentation

Clinically isolated syndrome in collagen diseases; approaches and treatments

Authors: Kazumasa Yokoyama, Nobutaka Hattori

Published in: Arthritis Research & Therapy | Special Issue 1/2012

Login to get access

Excerpt

Acute isolated neurological syndromes, such as optic neuropathy or transverse myelopathy, may cause diagnostic problems since they can be the first presentations in a number of demyelinating disorders including multiple sclerosis (MS) and collagen diseases. However, clinical presentation and lesions evidenced by magnetic resonance imaging may be similar. Collagen disease coexists in demyelinating disorders and frequently various collagen disease related autoantibodies are positive in daily practice. …
Literature
1.
go back to reference Franciotta D, Salvetti M: B cells and multiple sclerosis. Lancet Neurol. 2008, 7: 852-8. 10.1016/S1474-4422(08)70192-3.CrossRefPubMed Franciotta D, Salvetti M: B cells and multiple sclerosis. Lancet Neurol. 2008, 7: 852-8. 10.1016/S1474-4422(08)70192-3.CrossRefPubMed
2.
go back to reference Bernatsky S, Renoux C: Demyelinating events in rheumatoid arthritis after drug exposures. Ann Rheum Dis. 2010, 69: 1691-3. 10.1136/ard.2009.111500.CrossRefPubMed Bernatsky S, Renoux C: Demyelinating events in rheumatoid arthritis after drug exposures. Ann Rheum Dis. 2010, 69: 1691-3. 10.1136/ard.2009.111500.CrossRefPubMed
Metadata
Title
Clinically isolated syndrome in collagen diseases; approaches and treatments
Authors
Kazumasa Yokoyama
Nobutaka Hattori
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue Special Issue 1/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3559

Other articles of this Special Issue 1/2012

Arthritis Research & Therapy 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.